Gestational trophoblastic disease: Management of hydatidiform mole

Clinical Obstetrics and Gynecology

Volumn 46, Issue 3, 2003, Pages 557-569

  Hurteau, Jean A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; FOLINIC ACID; METHOTREXATE;

ANEMIA; CONFERENCE PAPER; DEHYDRATION; DISEASE CLASSIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY TERMINATION; RESPIRATORY DISTRESS; SYMPTOMATOLOGY; THYROTOXICOSIS; TROPHOBLASTIC DISEASE; TWIN PREGNANCY; UTERUS PERFORATION;

CHORIONIC GONADOTROPIN; FEMALE; HUMANS; HYDATIDIFORM MOLE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PREGNANCY; UTERINE NEOPLASMS;

EID: 0141563796     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200309000-00007     Document Type: Conference Paper

References (68)

1. Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. J Reprod. Med. 1994;39:155.
2. Takeuchi S. Incidence of gestational tropho-blastic disease by regional registration in Japan. Hum Reprod. 1987;2:729.
3. Berkowitz RS, Cramer DW, Bernstein MR, et al. Risk factors for complete molar pregnancy from a case-control study. Am J Obstet Gynecol. 1985; 152:1016.
4. Bagshawe KD, Dent J, Webb J. Hydatidiform mole in England and Wales 1973-1983. Lancet. 1986;2:673.
5. Parazzini F, LaVecchia C, Pampallona S. Parental age and risk of complete and partial hydatidiform mole. Br J Obstet Gynaecol. 1986;93:582.
6. Szulman AE, Surti U. The syndromes of hydatidiform mole: I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol. 1978;131:665.
7. Szulman AE, Surti U. The syndromes of hydatidiform mole: II. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol. 1978;132:20.
8. Surti U, Szulman AE, O'Brien S. Dispermic origin and clinical outcome of three complete hydatidiform moles with 46, XY karyotype. Am J Obstet Gynecol. 1982;144:84.
9. Fisher RA, Lawler SD. Heterozygous complete moles: do they have a worse prognosis than homozygous complete moles? Lancet. 1984;2:51.
10. Coukos G, Makrigiannakis A, Chung J, et al. Complete hydatidiform mole. A disease with a changing profile. J Reprod Med. 1999;44:698.
11. Berkowitz RS, Goldstein DP, DuBeshter B, et al. Management of complete molar pregnancy. J Reprod Med. 1987;32:634.
12. Montz FJ, Schlaerth JB, Morrow CP. The natural history of thecalutein cysts. Obstet Gynecol. 1988;72:247.
13. Twiggs LB, Morrow DP, Schlaerth JB. Acute pulmonary complications of molar pregnancy. Am J Obstet Gynecol. 1979;135:189.
14. Hankins GD, Wendel GD, Snyder RR, et al. Trophoblastic embolization during molar evacuation: central hemodynamic observations. Obstet Gynecol. 1987;69:368.
15. Jacobs PA, Szulman AE, Funkhouser J, et al. Human triploidy: relationship between paternal origin of the additional haploid complement and development of partial hydatidiform mole. Ann Hum Genet. 1982;46:223.
16. Lawler SD, Fisher RA, Pickthall VJ, et al. Genetic studies on hydatidiform moles. 1: The origin of partial moles. Cancer Genet Cytogenet. 1982;5:309.
17. Szulman AE, Surti U. The clinicopathologic profile of the partial hydatidiform mole. Obstet Gynecol. 1982;59:597.
18. Szulman AE, Surti U. The syndromes of hydatidiform moles. 1: Cytogenetic and morphologic correlations. Am J Obstet Gynecol. 1978;131:665.
19. Berkowitz RS, Goldstein DP, Bernstein MR. Natural history of partial molar pregnancy. Obstet Gynecol. 1986;66:677.
20. Jauniaux E, Kadri R, Hustin J. Partial mole and triploidy: screening patients with first trimester spontaneous abortion. Obstet Gynecol. 1996;88:616.
21. Berkowitz RS, Goldstein DP. The diagnosis of molar pregnancy by ultrasound- a continuing challenge. Ultrasound Obstet Gynecol. 1997;9:4.
22. Szulman AE. Trophoblastic disease: clinical pathology of hydatidiform moles. Obstet Gynecol Clin N Am. 1988;15:433.
23. Schlaerth JB, Morrow CP, Rodriguez M. Diagnositc and therapeutic curettage in gestational trophoblastic disease. Am J Obstet Gynecol. 1990;162:1465.
24. Schlaerth JB, Morrow CP, Montz FJ, et al. Initial management of hydatidiform mole. Am J Obstet Gynecol. 1988;158:1299.
25. Curry SL, Hammond CB, Tyrey L, et al. Hydatidiform mole: diagnosis, management and long-term follow up of 347 patients. Obstet Gynecol. 1975;45:1.
26. Tidy JA, Gillespie AM, Bright N, et al. Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy. Gynecol Oncol. 2000;78:309.
27. Bahar AM, el-Ashnei MS. Senthilsel van A. Hydatidiform mole in the elderly: hysterectomy or evacuation. Int J Obstet Gynecol. 1989;29:233.
28. Soper JT. Surgical therapy for gestational trophoblastic disease. J Reprod Med. 1994;39:168.
29. Kohom EI, McGinn RC, Bernard J, et al. Pulmonary embolism of trophoblastic tissue in molar pregnancy. Obstet Gynecol. 1978;51:16.
30. Cotton DB, Bernstein SG, Reed JA, et al. Hemodynamic observations in evacuation of molar pregnancy. Am J Obstet Gynecol. 1980;138:6.
31. Kohorn EI. Clinical management and the neoplastic sequelae of trophoblastic embolization associated with hydatidiform mole. Obstet Gynecol Surv. 1987;42:484.
32. Amir SM, Osathanoudh R, Berkowitz RS, et al. Human chorionic gonadotropin and thyroid function in patients with hydatidiform mole. Am J Obstet Gynecol. 1984;150:723.
33. Vejerslev LO. Clinical management and diagnostic possibilities in hydatiform mole with coexistent fetus. Obstet Gynecol Surv. 1991;46:577.
34. Miller D, Jackson R, Ehlen T, et al. Complete hydatiform mole coexistent with a twin live fetus: clinical course of 4 cases with complete cytogenetic analysis. Gynecol Oncol. 1993;50:119.
35. Steller MA, Genest DR, Bernstein MR, et al. Natural history of twin pregnancy with complete hydatidiform mole and coexisting fetus. 1994;83:35.
36. Jones WB, Lauersen NH. Hydatidiform mole with coexistent fetus. Am J Obstet Gynecol. 1975;122:267.
37. Block MF, Merrill JA. Hydatidiform mole with coexistent fetus. Obstet Gynecol. 1982;60:129.
38. Azuma C, Fumitaka S, Massahiko T, et al. Triplet pregnancy involving complete hydatidiform mole and two fetuses: genetic analysis by deoxyribonucleic acid fingerprint. Am J Obstet Gynecol. 1992;166:664.
39. Sauerbrei EE, Salem S, Fayle B. Coexistent hydatidiform mole and live fetus in the second rimester. Radiology. 1980;135:415.
40. Adachi N, Ihara Y, Ito H, et al. Two cases of twin pregnancy with complete hydatidiform mole and coexistent fetus. Acta Obstet Gynecol Jpn. 1992;44:1463.
41. Zbella EA, Vermesh M, Deppe G, et al. Coexistent complete hydatidiform mole and fetus after therapy with human menopausal gonadotropin. J Reprod Med. 1984;29:760.
42. Fishman DA, Padilla LA, Keh P, et al. Management of twin pregnancies consisting of complete hydatidiform mole and normal fetus. Obstet Gynecol. 1998;91:546.
43. Hertig AT, Sheldon WH. Hydatidiform mole: a pathologico-clinical correlation of 200 cases. Am J Obstet Gynecol; 1047;53:1.
44. Bandy LC, Clarke-Pearson DL, Hammond CB. Malignant potential of gestational trophoblastic disease at the extremes of reproductive life. Obstet Gynecol. 1984;138:6.
45. Parazzini F, Mangili G, Belloni C, et al. The problem of identification of prognostic factors for persistent trophoblastic disease. Gynecol Oncol. 1988;30:57.
46. Morrow CP, Kletzky OA, DiSaia PJ, et al. Clinical and laboratory correlates of molar pregnancy and trophoblastic disease. Am J Obstet Gynecol. 1977;128:424.
47. Khanlian SA, Smith HO, Cole LA. Persistent Low Levels of hCG: A pre-malignant gestational trophoblastic disease. Gynecol Oncol. 2003;88:200.
48. Ratnam SS, Teoh ES, Dawood MY. Methotrexate for prophylaxis of choriocarcinoma. Am J Obstet Gynecol. 1971;111:1021.
49. Kim DS, Moon H, Kim KT. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole. Obstet Gynecol. 1986;67:690.
50. Kashimura Y, Kashimura M, Sugimori H, et al. Prophylactic chemotherapy for hydatidiform moles. Five to 15 years follow up. Cancer. 1986;58:624.
51. Cole LA, Kohorn EI, Kim GS. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels. J Reprod Med. 1994;39:193.
52. Braunstein GD. False-positive serum human chorionic gonadotropin results: Causes, characteristics, and recognition. Am J Obstet Gynecol. 2002;187:217.
53. Curry SL, Schlaerth JB, Kohorn EI, et al. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group study). Am J Obstet Gynecol. 1989;160:805.
54. Elmer DB, Granai CO, Ball HG, et al. Persistence of gestation trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole. Obstet Gynecol. 1993;81:888.
55. Lurain JR, Brewer JI, Torok EE, et al. Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol. 1983;145:591.
56. Goldstein DP, Berkowitz RS. Current management of complete and partial molar pregnancy. J Reprod Med. 1994;39:139.
57. Acosta-Sison H. Is chorioadenoma destruens so benign that it cannot threaten the life of the patient? Philippine Med Assoc J. 1959;35:80.
58. Bagshawe KD, Wilson H, Dublon P, et al. Follow up after hydatidiform mole: studies using radioimmunoassays for urinary human chorionic gonadotropin (hCG). J Obstet Gynaecol Br Common. 1973;80:461.
59. Kohorn EI. Hydatidiform mole and gestational trophoblastic disease in southern Connecticut. Obstet Gynecol. 1982;59:78.
60. Kohorn EI, Goldstein DP, Hancock BW, et al. Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Health Organization for Trophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society. Int J Gynecol Cancer. 2000;10:84.
61. Flam F, Lundstrom V. The value of endometrial curettage in the follow up of hydatidiform mole. Acta Obstet Gynecol Scand. 1988;67:649.
62. Lao TT, Lee FH, Yeung SS. Repeat curettage after evacuation of hydatidiform mole. An appraisal. Acta Obstet Gynecol Scand. 1987;66:305.
63. Berkowitz RS, Goldstein DP, Bernstein MR, et al. Subsequent pregnancy outcomes in patients with molar pregnancies and gestational trophoblastic tumors. J Reprod Med. 1987;32:680.
64. Lurain JR, Sand PK, Carson SA, et al. Pregnancy outcome subsequent to consecutive hydatidiform moles. Am J Obstet Gynecol. 1982;142:1060.
65. Sand PK, Lurain JR, Brewer JI. Repeat gestational trophoblastic disease. Obstet Gynecol. 1984;63:140.
66. Matsui H, Iitsuka Y, Suzaka K, et al. Risk of abnormal pregnancy completing chemotherapy for gestational trophoblastic tumor. Gynecol Oncol. 2003;88:104.
67. Tuncer ZA, Bernstein MR, Goldstein DP, et al. Outcome of pregnancies occurring within 1 year of hydatidiform mole. Obstet Gynecol. 1999;94:588.
68. Tuncer ZS, Bernstein MR, Goldstein DP, et al. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor. Gynecol Oncol. 1999;73:343.